Back to Search
Start Over
Targeting CD70 in acute myeloid leukaemia: an emerging therapeutic angle in combinatorial treatment.
- Source :
-
The Lancet. Haematology [Lancet Haematol] 2023 Nov; Vol. 10 (11), pp. e868-e870. - Publication Year :
- 2023
-
Abstract
- Competing Interests: ATF reports consultation fees for Astellas, Bristol-Myers Squibb, Takeda, AbbVie Genentech, Daiichi Sankyo, PureTech, Pfizer, Rigel, Gilead, Amgen, Remix, Orum, Menarini, Ipsen, and clinical trial research grant support from Servier, Bristol-Myers Squibb, and AbbVie.
- Subjects :
- Humans
CD27 Ligand
Leukemia, Myeloid, Acute drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2352-3026
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The Lancet. Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 37914475
- Full Text :
- https://doi.org/10.1016/S2352-3026(23)00235-1